Of the 126 patients with NSCLC with an EGFR mutation, 79 (62.70%) showed low expression of ERCC1. Of the 131 patients with NSCLC with the wild-type EGFR gene, 56 (42.75%) had low expression of ERCC1 mRNA. Here, ERCC1 is linked to non-small cell lung carcinoma.